Product NDC: | 65649-551 |
Proprietary Name: | Relistor |
Non Proprietary Name: | Methylnaltrexone bromide |
Active Ingredient(s): | 12 mg/.6mL & nbsp; Methylnaltrexone bromide |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65649-551 |
Labeler Name: | Salix Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021964 |
Marketing Category: | NDA |
Start Marketing Date: | 20080801 |
Package NDC: | 65649-551-02 |
Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (65649-551-02) > .6 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 65649-551-02 |
Proprietary Name | Relistor |
Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (65649-551-02) > .6 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 65649-551 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Methylnaltrexone bromide |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20080801 |
Marketing Category Name | NDA |
Labeler Name | Salix Pharmaceuticals, Inc. |
Substance Name | METHYLNALTREXONE BROMIDE |
Strength Number | 12 |
Strength Unit | mg/.6mL |
Pharmaceutical Classes | Opioid Antagonist [EPC],Opioid Antagonists [MoA],Quaternary Ammonium Compounds [Chemical/Ingredient] |